The predictive value of the fine-needle aspiration diagnosis "Suspicious for a follicular neoplasm, Hürthle cell type" in patients with Hashimoto thyroiditis

American Journal of Clinical Pathology

Volumn 135, Issue 1, 2011, Pages 139-145

  Roh, Michael H ^a   Jo, Vickie Y ^b   Stelow, Edward B ^b   Faquin, William C ^c   Zou, Kelly H ^d   Alexander, Erik K ^e   Larsen, P Reed ^e   Marqusee, Ellen ^e   Benson, Carol B ^e   Frates, Mary C ^e   Gawande, Atul ^e   Moore Jr , Francis D ^e   Cibas, Edmund S ^e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d PFIZER INC   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atypia of undetermined significance; Cytology; Fine needle aspiration; Follicular neoplasm; Hashimoto thyroiditis; H rthle; Lymphocytic thyroiditis; Thyroid

Indexed keywords

LEVOTHYROXINE;

ARTICLE; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; CANCER RISK; COHORT ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FOLLOW UP; HASHIMOTO DISEASE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HURTHLE CELL CARCINOMA; LYMPHOCYTIC THYROIDITIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SUSPICIOUS FOR A FOLLICULAR NEOPLASM HURTHLE CELL TYPE; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PARAFOLLICULAR CELL; TOXIC GOITER;

BIOPSY, FINE-NEEDLE; CELL PROLIFERATION; HASHIMOTO DISEASE; HUMANS; OXYPHIL CELLS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; THYROID GLAND; THYROID NEOPLASMS;

EID: 79251514986     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP0RW2WMDUAKGK     Document Type: Article

References (22)

1. DeLellis RA, Lloyd RV, Heitz PU, et al, eds. IARC WHO Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004.
2. Thompson NW, Dunn EL, Batsakis JG, et al. Hürthle cell lesions of thyroid-gland. Surg Gynecol Obstet. 1974;139:555-560.
3. Hundahl SA, Fleming ID, Fremgen AM, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer. 1998;83:2638-2648.
4. Carcangiu ML, Bianchi S, Savino D, et al. Follicular Hürthle cell tumors of the thyroid gland. Cancer. 1991;68:1944-1953.
5. Gosain AK, Clark OH. Hürthle cell neoplasms: malignant potential. Arch Surg. 1984;119:515-519.
6. Evans HL, Vassilopoulou-Sellin R. Follicular and Hürthle cell carcinomas of the thyroid: a comparative study. Am J Surg Pathol. 1998;22:1512-1520. (Pubitemid 28550646)
7. Segev DL, Saji M, Phillips GS, et al. Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid. J Clin Endocrinol Metab. 1998;83:2036-2042.
8. Troncone G, Iaccarino A, Russo M, et al. Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hürthle cell) variant of follicular thyroid carcinoma. J Clin Pathol. 2007;60:377-381. (Pubitemid 46596555)
9. French CA, Alexander EK, Cibas ES, et al. Genetic and biological subgroups of low-stage follicular thyroid cancer. Am J Pathol. 2003;162:1053-1060.
10. Nikiforova MN, Lynch RA, Biddinger PW, et al. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab. 2003;88:2318-2326.
11. Yassa L, Cibas ES, Benson CB, et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer. 2007;111:508-516. (Pubitemid 350304903)
12. Elliott DD, Pitman MB, Bloom L, et al. Fine-needle aspiration biopsy of Hürthle cell lesions of the thyroid gland: a cytomorphologic study of 139 cases with statistical analysis. Cancer. 2006;108:102-109.
13. Amrikachi M, Ramzy I, Rubenfeld S, et al. Accuracy of fine-needle aspiration of thyroid: a review of 6226 cases and correlation with surgical or clinical outcome. Arch Pathol Lab Med. 2001;125:484-488.
14. Gharib H, Goellner JR, Johnson DA. Fine-needle aspiration cytology of the thyroid: a 12-year experience with 11,000 biopsies. Clin Lab Med. 1993;13:699-709.
15. Giorgadze T, Rossi EP, Fadda G, et al. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy? Diagn Cytopathol. 2004;31:307-312.
16. Pu RT, Yang J, Wasserman PG, et al. Does Hürthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn Cytopathol. 2006;34:330-334.
17. Baloch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36:425-437.
18. Montone KT, Baloch ZW, LiVolsi VA. The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Arch Pathol Lab Med. 2008;132:1241-1250.
19. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med. 1993;118:282-289.
20. Repplinger D, Bargren A, Zhang YW, et al. Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? J Surg Res. 2008;150:49-52.
21. Cibas ES, Ducatman BS. Cytology: Diagnostic Principles and Clinical Correlates. 3rd ed. Philadelphia, PA: Saunders; 2009.
22. Yang J, Schnadig V, Logrono R, et al. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007;111:306-315.